Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation (Q39928680)

15 September 2017

Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation (English)

1 reference

15 September 2017

4

1 reference

15 September 2017

Clifford C Taggart

3

0 references

author name string

Aileen M Gibbons

series ordinal

1

1 reference

PubMed ID

18925490

15 September 2017

Noel G McElvaney

series ordinal

2

1 reference

15 September 2017

1 September 2009

1 reference

Journal of Microencapsulation

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

513-522

1 reference

15 September 2017

6

1 reference

Steroid resistance in asthma. Molecular mechanisms

15 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Tryptase mediates hyperresponsiveness in isolated guinea pig bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

The effects of cholesterol inclusion on the vesicular membranes of cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Amphotericin B lipid complex therapy of experimental fungal infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Liposomes and nanoparticles in the treatment of intracellular bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Pulmonary delivery of insulin by liposomal carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Novel applications of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Organ-Selective Action of an Antitumor Drug: Pharmacologic Studies of Liposome-Encapsulated β-Cytosine Arabinoside Administered via the Respiratory System of the Rat2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Solid lipid nanoparticles: production, characterization and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Nebulization of liposomes. II. The effects of size and modeling of solute release profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Colorimetric determination of phospholipids with ammonium ferrothiocyanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Nebulization of liposomal rh-Cu/Zn-SOD with a novel vibrating membrane nebulizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02652040802466535

10.1080/02652040802466535

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

18925490